Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ODAC members

ODAC members

Member Expertise Term Affiliation
Otis Brawley Hematology, oncology 12/2/01-6/30/05 Associate director for cancer control at Winship

Read the full 185 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE